Josep M Alegret

Dr. Josep M Alegret

Cardiology, Hospital Universitari Sant Joan de Reus; Dep. Medicina i Cirurgia, Universitat Rovira i Virgili
orcid

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 April 2017 in Journal of Translational Medicine
Verified
Journal Article
Open access
PDF file
NMNeus Martínez-Micaelo
Neus Martínez-Micaelo
Raúl Beltrán-DebónRaúl Beltrán-Debón
Raúl Beltrán-Debón
IBIsabel Baiges
Isabel Baiges
MFMarta Faiges
Marta Faiges
JAJosep M Alegret
Josep M Alegret
We aimed to determine the circulating miRNA expression profile associated with BAV and aortic dilation to provide diagnostic and prognostic biomarkers for BAV and/or aortic dilation. We applied a miRNome-wide microarray approach using plasma samples (n = 24) from healthy tricuspid aortic valve individuals, BAV patients and BAV patients with aortic dilation to compare and identify the specific miRNAs associated with BAV and aortic dilation. In a second stage, the expression patterns of the miRNA candidates were validated by RT-qPCR in an independent cohort (n = 43). The miRNA microarray data and RT-qPCR analyses revealed that the expression levels of circulating miR-122, miR-130a and miR-486 are significantly influenced by the morphology of the aortic valve (bicuspid/tricuspid) and could be functionally involved in the regulation of TGF-β1 signalling. Furthermore, the expression pattern of miR-718 in the plasma was strongly influenced by dilation of the ascending aorta. miR-718 expression was inversely correlated with the aortic diameter (R = −0.63, p = 3.1 × 10−5) and was an independent predictor of aortic dilation (β = −0.41, p = 0.022). The genes targeted by miR-718 are involved in the regulation of vascular remodelling. We propose that miR-122, miR-130a, miR-486 and miR-718 are new molecular features associated with BAV and aortic dilation principally by the activation of TGF-β1 pathway and vascular remodelling mediated by VEGF signalling pathways.

1 December 2001 in European Heart Journal
Verified
Journal Article
Open access
PDF file
APAttila Pálinkás
Attila Pálinkás
EAE. Antonielli
E. Antonielli
EPE. Picano
E. Picano
APA. Pizzuti
A. Pizzuti
AVA. Varga
A. Varga
MCM. Csanády
M. Csanády
Background Echocardiographic parameters for predicting cardioversion outcome in patients with non-valvular atrial fibrillation are not accurately def

1 January 2015 in World Journal of Gastroenterology
Verified
Journal Article
Open access
NCNahum Calvo
Nahum Calvo
Raúl Beltrán-DebónRaúl Beltrán-Debón
Raúl Beltrán-Debón
EGEsther Rodríguez Gallego
Esther Rodríguez Gallego
AHAnna Hernández-Aguilera
Anna Hernández-Aguilera
MGMaria Guirro
Maria Guirro
Jorge JovenJorge Joven
Jorge Joven
AIM: To explore the usefulness of magnetic resonance imaging (MRI) and spectroscopy (MRS) for assessment of non-alcoholic fat liver disease (NAFLD) as compared with liver histological and metabolomics findings. METHODS: Patients undergoing bariatric surgery following procedures involved in laparoscopic sleeve gastrectomy were recruited as a model of obesity-induced NAFLD in an observational, prospective, single-site, cross-sectional study with a pre-set duration of 1 year. Relevant data were obtained prospectively and surrogates for inflammation, oxidative stress and lipid and glucose metabolism were obtained through standard laboratory measurements. To provide reliable data from MRI and MRS, novel procedures were designed to limit sampling variability and other sources of error using a 1.5T Signa HDx scanner and protocols acquired from the 3D or 2D Fat SAT FIESTA prescription manager. We used our previously described 1H NMR-based metabolomics assays. Data were obtained immediately before surgery and after a 12-mo period including histology of the liver and measurement of metabolites. Values from 1H NMR spectra obtained after surgery were omitted due to technical limitations. RESULTS: MRI data showed excellent correlation with the concentration of liver triglycerides, other hepatic lipid components and the histological assessment, which excluded the presence of non-alcoholic steatohepatitis (NASH). MRI was sufficient to follow up NAFLD in obese patients undergoing bariatric surgery and data suggest usefulness in other clinical situations. The information provided by MRS replicated that obtained by MRI using the -CH3 peak (0.9 ppm), the -CH2- peak (1.3 ppm, mostly triglyceride) and the -CH=CH- peak (2.2 ppm). No patient depicted NASH. After surgery all patients significantly decreased their body weight and steatosis was virtually absent even in patients with previous severe disease. Improvement was also observed in the serum concentrations of selected variables. The most relevant findings using metabolomics indicate increased levels of triglyceride and monounsaturated fatty acids in severe steatosis but those results were accompanied by a significant depletion of diglycerides, polyunsaturated fatty acids, glucose-6-phosphate and the ATP/AMP ratio. Combined data indicated the coordinated action on mitochondrial fat oxidation and glucose transport activity and may support the consideration of NAFLD as a likely mitochondrial disease. This concept may help to explain the dissociation between excess lipid storage in adipose tissue and NAFLD and may direct the search for plasma biomarkers and novel therapeutic strategies. A limitation of our study is that data were obtained in a relatively low number of patients. CONCLUSION: MRI is sufficient to stage NAFLD in obese patients and to assess the improvement after bariatric surgery. Other data were superfluous for this purpose.

4 February 2013 in European Journal of Clinical Investigation
Verified
Journal Article
Closed access
PDF file
JAJosep M Alegret
Josep M Alegret
Gerard AragonèsGerard Aragonès
Gerard Aragonès
RERoberto Elosua
Roberto Elosua
Raúl Beltrán-DebónRaúl Beltrán-Debón
Raúl Beltrán-Debón
AHAnna Hernández-Aguilera
Anna Hernández-Aguilera
Jorge JovenJorge Joven
Jorge Joven

1 February 2012 in Atherosclerosis
Verified
Journal Article
Closed access
Anna RullAnna Rull
Anna Rull
RGRaúl García
Raúl García
LFLaura Fernández-Sender
Laura Fernández-Sender
AGAnabel García-Heredia
Anabel García-Heredia
Gerard AragonèsGerard Aragonès
Gerard Aragonès
Jordi CampsJordi Camps
Jordi Camps

1 March 2003 in The American Journal of Cardiology
Verified
Journal Article
Closed access
JAJosep M Alegret
Josep M Alegret
IDIgnasi Duran
Ignasi Duran
OPOscar Palazón
Oscar Palazón
JVJosep M. Vernis
Josep M. Vernis
AAAlberto Ameijide
Alberto Ameijide
LMLluís Masana
Lluís Masana